Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission

Vaccine

Volumn 30, Issue 13, 2012, Pages 2336-2341

  Lin, Guang Jan ^a   Deng, Ming Chung ^b   Chen, Zeng Weng ^a   Liu, Ting Yu ^a   Wu, Ching Wei ^a   Cheng, Chih Yuan ^a   Chien, Maw Sheng ^a   Huang, Chienjin ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b FISHERIES RESEARCH INSTITUTE   (Taiwan)

Author keywords

Classical swine fever virus; Protective immune response; Subunit marker vaccine; Virus horizontal transmission; Yeast expressed E2 protein

Indexed keywords

GLYCOPROTEIN E2; NEUTRALIZING ANTIBODY; SUBUNIT VACCINE; VIRUS VACCINE;

ANIMAL CELL; ANTIBODY TITER; ARTICLE; CLASSICAL SWINE FEVER; CONTROLLED STUDY; CROSS PROTECTION; DRUG EFFICACY; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION PREVENTION; NONHUMAN; OPTIMAL DRUG DOSE; PICHIA PASTORIS; PRIORITY JOURNAL; SEROCONVERSION; VIRUS HORIZONTAL TRANSMISSION; VIRUS TRANSMISSION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; DISEASE TRANSMISSION, INFECTIOUS; PICHIA; SWINE; VACCINES, SUBUNIT; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 84862819014     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.01.051     Document Type: Article

References (35)

1. Lindenbach B.D., Rice C.N. Flaviviridae: the viruses and their replication. Fields virology 2001, 991-1041. Lippincott Williams & Wilkins, Philadelphia. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Rzman (Eds.).
2. Liess B. Pathogenesis and epidemiology of hog cholera. Ann Rech Vet 1987, 18(2):139-145.
3. Moennig V., Plagemann P.G.W. The Pestiviruses. Advances in virus research 1992, 53-98. Academic Press. F.A.M. Karl Maramorosch, J.S. Aaron (Eds.).
4. Rumenapf T., Unger G., Strauss J.H., Thiel H.J. Processing of the envelope glycoproteins of pestiviruses. J Virol 1993, 67(6):3288-3294.
5. Schneider R., Unger G., Stark R., Schneider-Scherzer E., Thiel H.J. Identification of a structural glycoprotein of an RNA virus as a ribonuclease. Science 1993, 261(5125):1169-1171.
6. Hulst M.M., Himes G., Newbigin E., Moormann R.J. Glycoprotein E2 of classical swine fever virus: expression in insect cells and identification as a ribonuclease. Virology 1994, 200(2):558-565.
7. Windisch J.M., Schneider R., Stark R., Weiland E., Meyers G., Thiel H.J. RNase of classical swine fever virus: biochemical characterization and inhibition by virus-neutralizing monoclonal antibodies. J Virol 1996, 70(1):352-358.
8. van Zijl M., Wensvoort G., de Kluyver E., Hulst M., van der Gulden H., Gielkens A., et al. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J Virol 1991, 65(5):2761-2765.
9. Hulst M.M., Westra D.F., Wensvoort G., Moormann R.J. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J Virol 1993, 67(9):5435-5442.
10. van Rijn P.A., Bossers A., Wensvoort G., Moormann R.J. Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge. J Gen Virol 1996, 77(Pt. 11):2737-2745.
11. Weiland E., Ahl R., Stark R., Weiland F., Thiel H.J. A second envelope glycoprotein mediates neutralization of a pestivirus, hog cholera virus. J Virol 1992, 66(6):3677-3682.
12. van Rijn P.A., van Gennip H.G., de Meijer E.J., Moormann R.J. Epitope mapping of envelope glycoprotein E1 of hog cholera virus strain Brescia. J Gen Virol 1993, 74(Pt. 10):2053-2060.
13. Konig M., Lengsfeld T., Pauly T., Stark R., Thiel H.J. Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J Virol 1995, 69(10):6479-6486.
14. Bouma A., De Smit A.J., De Jong M.C., De Kluijver E.P., Moormann R.J. Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus. Vaccine 2000, 18(14):1374-1381.
15. Vandeputte J., Chappuis G. Classical swine fever: the European experience and a guide for infected areas. Rev Sci Tech 1999, 18(3):638-647.
16. Moennig V. Introduction to classical swine fever: virus, disease and control policy. Vet Microbiol 2000, 73(2-3):93-102.
17. van Oirschot J.T. Vaccinology of classical swine fever: from lab to field. Vet Microbiol 2003, 96(4):367-384.
18. van Oirschot J.T. Diva vaccines that reduce virus transmission. J Biotechnol 1999, 73(2-3):195-205.
19. Paton D. Classical swine fever - an update. Res Vet Sci 2003, 75(3):169-178.
20. Lin G.-J., Liu T.-Y., Tseng Y.-Y., Chen Z.-W., You C.-C., Hsuan S.-L., et al. Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response. Vet Microbiol 2009, 139(3-4):369-374.
21. Huang C., Chien M.-S., Hu C.-M., Chen C.-W., Hsieh P.-C. Secreted expression of the classical swine fever virus glycoprotein Erns in yeast and application to a sandwich blocking ELISA. J Virol Methods 2006, 132(1-2):40-47.
22. Deng M.C., Huang C.C., Huang T.S., Chang C.Y., Lin Y.J., Chien M.S., et al. Phylogenetic analysis of classical swine fever virus isolated from Taiwan. Vet Microbiol 2005, 106(3-4):187-193.
23. Lin Y.J., Chien M.S., Deng M.C., Huang C.C. Complete sequence of a subgroup 3.4 strain of classical swine fever virus from Taiwan. Virus Genes 2007, 35(3):737-744.
24. Reed L.J., Münch H. A simple method of estimating fifty percent endpoints. Am J Epidemiol 1938, 27(3):493-497.
25. Mittelholzer C., Moser C., Tratschin J.D., Hofmann M.A. Analysis of classical swine fever virus replication kinetics allows differentiation of highly virulent from avirulent strains. Vet Microbiol 2000, 74(4):293-308.
26. Terpstra C., Bloemraad M., Gielkens A.L. The neutralizing peroxidase-linked assay for detection of antibody against swine fever virus. Vet Microbiol 1984, 9(2):113-120.
27. de Smit A.J. Laboratory diagnosis, epizootiology, and efficacy of marker vaccines in classical swine fever: a review. Vet Q 2000, 22(4):182-188.
28. Moormann R.J., Bouma A., Kramps J.A., Terpstra C., De Smit H.J. Development of a classical swine fever subunit marker vaccine and companion diagnostic test. Vet Microbiol 2000, 73(2-3):209-219.
29. Zhu X., Wu S., Letchworth G.J. A chimeric protein comprised of bovine herpesvirus type 1 glycoprotein D and bovine interleukin-6 is secreted by yeast and possesses biological activities of both molecules. Vaccine 1999, 17(3):269-282.
30. Cereghino J.L., Cregg J.M. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev 2000, 24(1):45-66.
31. Jiang W.Z., Jin N.Y., Li Z.J., Zhang L.S., Wang H.W., Zhang Y.J., et al. Expression and characterization of Gag protein of HIV-1(CN) in Pichia pastoris. J Virol Methods 2005, 123(1):35-40.
32. Paton D.J., McGoldrick A., Greiser-Wilke I., Parchariyanon S., Song J.Y., Liou P.P., et al. Genetic typing of classical swine fever virus. Vet Microbiol 2000, 73(2-3):137-157.
33. Dewulf J., Laevens H., Koenen F., Mintiens K., de Kruif A. An E2 sub-unit marker vaccine does not prevent horizontal or vertical transmission of classical swine fever virus. Vaccine 2002, 20(1-2):86-91.
34. Donahue B.C., Petrowski H.M., Melkonian K., Ward G.B., Mayr G.A., Metwally S. Analysis of clinical samples for early detection of classical swine fever during infection with low, moderate, and highly virulent strains in relation to the onset of clinical signs. J Virol Methods 2012, 179(1):108-115.
35. Terzic S., Jemersic L., Lojkic M., Madic J., Grom J., Toplak I., et al. Comparison of antibody values in sera of pigs vaccinated with a subunit or an attenuated vaccine against classical swine fever. Vet Res Commun 2003, 27(4):329-339.